DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Clinical Autonomic Research Année : 2010

DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa.

Résumé

We describe the effects of chronic droxidopa in a patient with Dopamine beta-hydroxylase deficiency diagnosed at the age of 73. Investigations were performed to assess sympathetic activity (MIBG scintigraphy, catecholamines) and cardiovascular droxidopa safety.

Dates et versions

inserm-00504967 , version 1 (22-07-2010)

Identifiants

Citer

Fabien Despas, Atul Pathak, M. Berry, R. Cagnac, P. Massabuau, et al.. DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa.. Clinical Autonomic Research, 2010, 20 (3), pp.205-7. ⟨10.1007/s10286-009-0049-7⟩. ⟨inserm-00504967⟩
27 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More